These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 12503474

  • 21. beta-Blocker therapy in heart failure.
    Doughty RN.
    Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [Abstract] [Full Text] [Related]

  • 23. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H.
    Int J Cardiol; 2005 Aug 18; 103(2):182-6. PubMed ID: 16080978
    [Abstract] [Full Text] [Related]

  • 24. [Chronic heart failure and sudden death: the message of CIBIS-III].
    Dequarti MC, Poggio L, Vanoli E.
    Recenti Prog Med; 2007 Dec 18; 98(12):638-45. PubMed ID: 18369041
    [Abstract] [Full Text] [Related]

  • 25. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
    Krum H, Shi H, Pitt B, McMurray J, Swedberg K, van Veldhuisen DJ, Vincent J, Pocock S, Zannad F, EMPHASIS-HF Study Group.
    Circ Heart Fail; 2013 Jul 18; 6(4):711-8. PubMed ID: 23625945
    [Abstract] [Full Text] [Related]

  • 26. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
    Krum H, Bailey M, Meyer W, Verkenne P, Dargie H, Lechat P, Anker S.
    Cardiology; 2007 Jul 18; 108(1):28-34. PubMed ID: 16960445
    [Abstract] [Full Text] [Related]

  • 27. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure.
    Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT, Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) Study Group.
    Circulation; 2010 Mar 09; 121(9):1086-95. PubMed ID: 20176990
    [Abstract] [Full Text] [Related]

  • 28. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
    Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, Wagner B, Pacher R.
    J Am Coll Cardiol; 2010 Feb 16; 55(7):645-53. PubMed ID: 20170790
    [Abstract] [Full Text] [Related]

  • 29. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
    Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.
    Eur Heart J; 2005 Oct 16; 26(20):2154-8. PubMed ID: 16014644
    [Abstract] [Full Text] [Related]

  • 30. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
    Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, Tavazzi L, Poole-Wilson P, Le Pen C.
    Eur Heart J; 2005 Aug 16; 26(16):1653-9. PubMed ID: 15827061
    [Abstract] [Full Text] [Related]

  • 31. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G, Di Lenarda A, Metra M, Nodari S, Moretti M, Brentana L, Dei Cas L, Sinagra G.
    Ital Heart J; 2004 Dec 16; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [Abstract] [Full Text] [Related]

  • 32. Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I.
    Komajda M, Hanon O, Hochadel M, Follath F, Swedberg K, Gitt A, Cleland JG.
    Eur Heart J; 2007 Jun 16; 28(11):1310-8. PubMed ID: 17185303
    [Abstract] [Full Text] [Related]

  • 33. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators.
    Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343
    [Abstract] [Full Text] [Related]

  • 34. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar 29; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 35. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E, Perez-Villa F, Morales M, Jiménez W, Orús J, Heras M, Sanz G.
    Eur Heart J; 2000 Jan 29; 21(1):53-7. PubMed ID: 10610744
    [Abstract] [Full Text] [Related]

  • 36. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.
    Am Heart J; 2008 Oct 29; 156(4):662-73. PubMed ID: 18926148
    [Abstract] [Full Text] [Related]

  • 37. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M, French National College of Cardiologists.
    Arch Cardiovasc Dis; 2012 Oct 29; 105(6-7):355-65. PubMed ID: 22800720
    [Abstract] [Full Text] [Related]

  • 38. [Medical treatment of heart failure: an analysis of actual treatment practices in outpatients in Switzerland. The Swiss "IMPROVEMENT of HF" Group].
    Muntwyler J, Follath F.
    Schweiz Med Wochenschr; 2000 Aug 26; 130(34):1192-8. PubMed ID: 11013922
    [Abstract] [Full Text] [Related]

  • 39. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
    Tarantini L, Faggiano P, Senni M, Lucci D, Bertoli D, Porcu M, Opasich C, Tavazzi L, Maggioni AP.
    Ital Heart J; 2002 Nov 26; 3(11):656-64. PubMed ID: 12506524
    [Abstract] [Full Text] [Related]

  • 40. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS, Bredikis A, Habib G, Carabello BA, Ramasubbu K, Bozkurt B.
    Am J Cardiol; 2008 Nov 15; 102(10):1356-60. PubMed ID: 18993155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.